World Market for Gastrointestinal Devices (Rigid, Flexible and Capsule Endoscopes, Bariatric Surgery, Ostomy Products, Enteral Feeding Pumps and Other Devices)

Kalorama Information
January 1, 2012
200 Pages - SKU: KLI6710760
License type:
Table of Contents Related Reports
Countries covered: Global

This report, The World Market for Gastrointestinal Devices, details the market for endoscopes and other devices used for treating gastrointestinal conditions. There are many factors behind the growth of this market. Cancer is one of leading reasons for surgery with more than 1 million new cases of colorectal cancer reported each year around the world. Obesity is another reason for growth. More and more people worldwide are turning to gastric bypass (bariatric surgery) and gastric banding to aide in their weight loss, thus increasing the need for gastrointestinal endoscopy.

Improved technology is another driver for the market. Newer technologies such as capsule endoscopy and other devices have also increased this market. These miniaturized in-vivo robots assist by performing several surgical functions such as visualization, but are not attached to or constrained by laparoscopic tool lever arms. Using robotic cameras inside the body simplifies port and tool placement.

Kalorama's World Market for Gastrointestinal Equipment provides device marketers, manufacturers and investors with market sizes and forecasts for gastrointestinal devices, and equipment, including the following segments:

  • Endoscopes (Rigid, Flexible)
  • Capsule Endoscopes
  • Bariatric Surgery Devices
  • Ostomy Products
  • Enteral Feeding Pumps
  • Other
In addition the report provides the following important data to understanding the gastrointestinal device market:
  • Regional Breakout of Market (US, Europe, Japan, ROW)
  • Product Offerings of Major Vendors
  • Market Share by Major Vendor
  • Recent Mergers and Acquisitions
  • Discussion of Key Industry Trends
  • U.S. and Europe Procedure Volumes (Appendectomy, Bariatric Surgery, Cholecystectomy, Endoscopy, Intestine Transplant, Liver Transplant, Pancreas Transplant)
  • Drivers of Conditions: Stress, Alchohol, Smoking and Caffeine Consumption.
  • Information on Reimbursement of Bariatric Surgery, Upper GI/Colonoscopy, and Cholecystectomy
  • Profiles of Leading Instrument and Equipment Suppliers

Knowing the competitors operating in any device market is crucial to understanding the opportunities. Kalorama has analyzed the key companies in the GI space. Coverage the following companies is included:

  • Boston Scientific Corporation
  • Conmed Corporation
  • Covidien Ltd.
  • Fujinon
  • Given Imaging, Ltd.
  • Johnson & Johnson (Ethicon Endo-Surgery)
  • Karl Storz GmbH & Co KG
  • Olympus Corporation
  • Pentax
  • Stryker Corporation
  • Welch Allyn
In the development of this Kalorama report, research into corporate publications, annual reports, government databases and medical journals was enhanced by a primary research effort involving interviews with market experts and executives to obtain important insights, confirm trends and market forecasts.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.

For Kalorama's take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information's Key Point Blog at http://kaloramakeypoint.blogspot.com/




Additional Information

As 'Next Tier Patients' Undergo Gastric Banding and Bypass, GI Device Market Grows

Once an experimental procedure for severely obese people, gastric bypass, and particularly banding, have become more common, driving gastrointestinal device sales, according to healthcare market research publisher Kalorama Information. The number of procedures for gastric banding has increased 22 times since the early 90's according to Kalorama, and this trend is driving the gastrointestinal device market to $14.6 billion in sales. The findings were published in the firm's latest report, The World Market for Gastrointestinal Devices.

"Gastric banding used to be the last resort for the morbidly obese, those who needed to lose in excess of one hundred pounds," said Bruce Carlson, publisher of Kalorama Information. "Now you see procedures for 'next tier' patients, those who are unsuccessful after repeated attempts to reduce their weight through diet and exercise."

Concerns about more threatening conditions such as diabetes and heart disease are encouraging the 'next tier' procedure decisions, Carlson indicated. Procedure volumes were minimal in 1993, with about 16,800 reported for the year. Today, industry sources estimate that there were about 370,000 procedures in 2009. Women account for the largest percentage of these procedures with about 84 percent. And women in their late 30s to early 40s are the most common age group for this procedure.

The device most commonly used to treat obesity is the adjustable gastric band. Banding devices are made of inert materials such as silicone and are implanted around the proximal stomach to decrease food intake. As the world's largest healthcare market continues to struggle with rapidly increasing obesity rates, the U.S. market for devices is expected increase. Paré Surgical Inc, Allergan, Surgical-IOC, Medical Innovation Development, Ethicon Endo-Surgery, Cousin Biotech, Helioscopie SA, and Silimed are among the companies who manufacture these types of devices.

Despite a great deal of publicity about obesity, there continues to be a considerable increase in the incidence of obesity in the U.S. In 2007, more than 65 percent of U.S. states had rates of obesity between 25 and 30 percent, and not a single state had levels less than 18 percent.

This Kalorama Information report includes information on this device market, including products, key players and noticeable trends.

More Global Gastrointestinal Reports

The World Market for Over The Counter (OTC) Drugs by Kalorama Information
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription.  Many pharmaceutical companies seeking more revenue and ...

Constipation Global Clinical Trials Review, H1, 2012 by GlobalData
Constipation Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, H1, 2012 provides data on the Constipation clinical trial scenario. ...

Gastrointestinal (GI) Endoscopy Devices by Global Industry Analysts
This report analyzes the US market for Gastrointestinal (GI) Endoscopy Devices in US$ Million by the following Product Segments: GI Videoscopes (Video Colonoscopes, Video Gastroscopes, ...

Bariatric (Obesity) Surgical Devices by Global Industry Analysts
This report analyzes the US and European markets for Bariatric (Obesity) Surgical Devices in US$ Million. The US market is analyzed by the following ...

Endoscopy Systems by Global Industry Analysts
This report analyzes the worldwide markets for Endoscopy Systems in US$ Million by the following Product Segments: Endoscopes, and Visualization Equipment. The report provides separate ...

See all reports like this >>

 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Gastrointestinal Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!